Candriam S.C.A. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,450,645
+43.6%
135,709
+35.7%
0.12%
+41.0%
Q2 2023$11,452,000
-26.1%
100,000
-18.2%
0.08%
-23.1%
Q1 2023$15,501,863
+25.7%
122,194
+28.4%
0.11%
+30.1%
Q4 2022$12,328,182
-54.1%
95,144
-42.0%
0.08%
-62.9%
Q1 2021$26,859,000
-3.9%
164,0080.0%0.22%
+1.4%
Q4 2020$27,963,000
+13.9%
164,008
-6.2%
0.22%
-4.3%
Q3 2020$24,550,000
-12.4%
174,8290.0%0.23%
-22.0%
Q2 2020$28,033,000
+34.6%
174,829
+5.9%
0.30%
+28.1%
Q1 2020$20,826,000
-2.2%
165,1000.0%0.23%
+1.3%
Q4 2019$21,305,000
+46.9%
165,100
-14.3%
0.23%
+18.8%
Q3 2019$14,507,000
-50.2%
192,6000.0%0.19%
-47.1%
Q2 2019$29,137,000
+26.9%
192,6000.0%0.36%
+23.5%
Q1 2019$22,957,000
+66.8%
192,600
+52.7%
0.29%
+39.3%
Q4 2018$13,761,000
-30.8%
126,100
+2.4%
0.21%
-20.1%
Q3 2018$19,882,000
+154.9%
123,100
+108.6%
0.26%
+114.6%
Q2 2018$7,799,000
+119.3%
59,000
+22.9%
0.12%
+101.6%
Q1 2018$3,556,000
+52.2%
48,000
+14.3%
0.06%
+52.5%
Q4 2017$2,337,000
+179.9%
42,000
-2.3%
0.04%
+90.5%
Q1 2016$835,000
+8.2%
43,000
+115.0%
0.02%0.0%
Q4 2015$772,000
-42.5%
20,000
-52.2%
0.02%
-36.4%
Q3 2015$1,342,000
+10.3%
41,800
+4.5%
0.03%
+32.0%
Q2 2015$1,217,000
+30.9%
40,000
-42.9%
0.02%
+31.6%
Q1 2015$930,000
+7.1%
70,000
+16.7%
0.02%
+5.6%
Q4 2014$868,00060,0000.02%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders